Sector studies

When looking for sources of inspiration for developing a CVC management protocol, we realized that international guidelines often encourage the use of chlorhexidine for skin antisepsis. These guidelines are not always clear regarding its use, its concentration, the type of solution, whether aqueous or alcoholic etc. In addition, any interaction and the safety of this substance with the materials that make up the CVC are not taken into account. These unanswered questions prompted us to verify the efficacy of alternative products to Chlorhexidine in alcohol, and their tolerability by the materials in order to create an ad hoc protocol for our operational...

Peritoneal catheter exit-site infections are still frequent complications for patients doing peritoneal dialysis. Not only are they risk factors for the development of tunnel infections, but also peritonitis due to the infection developing in the peritoneal cavity. Advances made over the past two decades in the prevention and treatment of peritonitis and technical improvements in materials have significantly reduced the incidence of these infections. For several years, an advanced medication, EXIT-PAD Ag by Emodial, has been available, designed for the exit-sites of peritoneal dialysis catheters and CVCs for haemodialysis. EXIT-PAD Ag is a dressing consisting of a mesh with the controlled release of silver...

The main clinical problems related to CVC exit-site management are complications due to infection, in particular CRBSI, which impact negatively on hospitalization, survival and the incidence of mortality, thereby increasing hospital and care costs. Understanding the sequence of clinical and care events that lead to infections allows us to develop rational preventive strategies. As has already been demonstrated, keeping to strict vascular access management protocols can lead to a reduction in the incidence of CRBSI, but the unity of the nursing team and the supervision by the person responsible for vascular access is also necessary and important. Find out about the study...